Meaghan Dendy Case, MD, MA
Section: Interventional Radiology
Meaghan Dendy Case, MD, MA, received her medical degree from Drexel University in 2017.
For residency, Dr. Dendy Case trained in diagnostic and interventional radiology at Yale School of Medicine, serving as Chief Resident for interventional radiology.
Prior, Dr. Dendy Case attended Wesleyan University, where she completed her undergraduate studies in both biology and neuroscience. She received her master's degree in biotechnology from Columbia University.
Before attending medical school, Dr. Dendy Case worked as a Senior Scientist at Mount Sinai Hospital in New York, a Lab Technician at Columbia University Medical Center, and as a Thoracic Surgery Research Associate at Yale University. She joined VUMC Radiology's interventional radiology section as an Assistant Professor in 2023.
Research Information
Publications:
Uhlig J, Mehta S, Case MD, Dhanasopon A, Blasberg J, Homer RJ, Solomon SB, Kim HS. Effectiveness of Thermal Ablation and Stereotactic Radiotherapy Based on Stage I Lung Cancer Histology. J Vasc Interv Radiol. 2021 Jul;32(7):1022-1028.e4. doi: 10.1016/j.jvir.2021.02.025. Epub 2021 Mar 31. PMID: 33811997.
Dendy MS, Ludwig JM, Stein SM, Kim HS. Locoregional Therapy, Immunotherapy and the Combination in Hepatocellular Carcinoma: Future Directions. Liver Cancer. 2019 Oct;8(5):326-340. doi: 10.1159/000494843. Epub 2019 Jan 16. PMID: 31768343; PMCID: PMC6873025.
Uhlig J, Case MD, Blasberg JD, Boffa DJ, Chiang A, Gettinger SN, Kim HS. Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non-Small Cell Lung Cancer. JAMA Netw Open. 2019 Aug 2;2(8):e199702. doi: 10.1001/jamanetworkopen.2019.9702.
Stähr K, Eckstein A, Holtmann L, Schlüter A, Dendy M, Lang S, Mattheis S. A comparative analysis of piezosurgery and oscillating saw for balanced orbital decompression. Orbit. 2018 Dec 4:1-7. doi: 10.1080/01676830.2018.1552709.
Dendy MS, Ludwig JM, Kokabi N, Stein SM, Lacy J, Hochster HS, Kim HS. Genomic mutations and histopathologic biomarkers in Y90 radioembolization for chemorefractory colorectal liver metastases. Oncotarget. 2018 Aug 21;9(65):32523-32533. doi: 10.18632/oncotarget.25992. eCollection 2018 Aug 21.
Dendy MS, Camacho JC, Ludwig JM et al. Infiltrative Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis Treated With a Single High-Dose Y90 Radioembolization and Subsequent Liver Transplantation Without a Recurrence. Transplant Direct 2017; 3: e206.
Akinwande O, Dendy M, Ludwig JM, Kim HS. Hepatic intra-arterial injection of irinotecan drug eluting beads (DEBIRI) for patients with unresectable colorectal liver metastases: A systematic review. Surg Oncol 2017; 26: 268-275.
Stahr, K., Kuechler, A., Gencik, M., Arnolds, J., Dendy, M., Lang, S., & Arweiler-Harbeck, D. (2017). Cochlear Implantation in Siblings With Refsum's Disease. Ann Otol Rhinol Laryngol, 126(8), 611-614. doi:10.1177/0003489417717269
Dendy MS, Ludwig JM, Kim HS. Predictors and prognosticators for survival with Yttrium-90 radioembolization therapy for unresectable colorectal cancer liver metastasis. Oncotarget 2017; 8: 37912-37922.
She QB, Gruvberger-Saal S, Maurer M, Chen Y, Jumppanen M, Su T, Dendy M, Lau YKL, Memeo L, Isola J, Hibshoosh H, Rosen N, Parsons R, Saal L. 2016. Integrated molecular pathway analysis informs a synergistic combination therapy targeting PTEN/PI3K and EGFR pathways for basal-like breast cancer. BMC Cancer. 16(1):587.
Dendy M, Johnson K, Boffa DJ. Spectrum of FDG uptake in large (>10 cm) esophageal leiomyomas. 2015. J Thorac Dis. 7(12):E648-51.
Stratikopoulos EE, Dendy M, Szabolcs M, Khaykin AJ, Lefebvre C, Zhou MM, Parsons R. 2015. Kinase and BET Inhibitors Together Clamp Inhibition of PI3K Signaling and Overcome Resistance to Therapy. Cancer Cell, 27 (6):837-51.
Hopkins BD, Fine B, Steinbach N, Dendy M, Rapp Z, Shaw J, Pappas K, Yu JS, Hodakoski C, Mense S, Klein J, Pegno S, Sulis ML, Goldstein H, Amendolara B, Lei L, Maurer M, Bruce J, Canoll P, Hibshoosh H, and Parsons R. 2013. A Secreted PTEN Phosphatase That Enters Cells to Alter Signaling and Survival. Science, 341 (6144), 399-402.